참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Sodium Carbonate | HCID 10340 | — |
| 반응물 | 4-Carboxyphenylboronic Acid | HCID 312183 | — |
| 반응물 | 6-Trifluoromethylsulfonyloxy-8-methoxy-1,7-naphthyridine | HCID 23284635 | — |
| 촉매 | Tri-o-tolylphosphine | HCID 80271 | — |
| 촉매 | 1,5-Diphenylpenta-1,4-dien-3-one;palladium | HCID 154270 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 6-(4-Carboxyphenyl)-8-methoxy-1,7-naphthyridine | HCID 23284642 | 80.8% |
반응 단계
To a solution of 6-trifluoromethylsulfonyloxy-8-methoxy-1,7-napthyridine (1.5 g, 4.86 mmol) in DMF (40 ml) is added 4-carboxy-phenylboronic acid (0.866 g, 5.34 mmol), bis(dibenzylidenacetone) palladium (112 mg, 0.167 mmol), tri-o-tolylphosphine (96 mg, 0.32 mmol) and aqueous Na2CO3 (14.6 ml, 2N,). The reaction mixture is stirred at 110° for 3 h. The hot solution is filtred through cellit and the solution evaporated to dryness. The crude product is dissolved in hot water (60 ml) and the water phase washed with ethyl acetate (3×50 ml). The product is precipitated from the water phase by carefully adding aqueous HCl (2N, 6 ml). The suspension is filtered and the crude product is stirred again in hot ethyl acetate (50 ml). The cold suspension is filtered to yield the title compound (1.10 g). M+280; Melting point >300°.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06136821 |
|---|
| 출처 데이터셋 | uspto-grants-2000_10 |
|---|
| ORD ID | ord-449fc1ba55304cbb90163e63a52ba620 |
|---|
| 출처 메모 | uspto-grants-2000_10 |
|---|